Mechanisms of drug-resistance and analysis of drug-resistant genes in Leishmania
利什曼原虫耐药机制及耐药基因分析
基本信息
- 批准号:05670243
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1993
- 资助国家:日本
- 起止时间:1993 至 1994
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A protozoan parasite, Leishmania, contains several P-glycoprotein genes as a multigene family. Two types of the gene (Ldmdrl and LtpgpA) have been isolated from different Leishmania species, and found to play a role of drug-resistance. In this study, we aimed to isolate and characterize P-glycoprotein genes in L.amazonensis, one of the causative agents of cutaneous leishmaniasis in the New World. Polymerase chain reaction (PCR) was performed to amplify ATP binding sites within P-glycoproteins of L.amazonensis by using primers specific to conserved sequences in mammalian and leishmanial P-glycoprotein genes. We detected a 408-bp PCR product which showed 68% and 37% identity to Ldmdrl and LtpgpA,respectively, at the amino acid level, suggesting that this DNA fragment is in part of new type of leishmanial P-glycoprotein gene. To isolate the putative gene in whole, a genomic library of L.amazonensis DNA was constructed into the lambda-GEM-11 vector and screened with the PCR product. One of the positive lambda clones was digested with Sac I restriction endonuclease, and resultant DNA fragments were subcloned into pUC19 vector. At present, nucleotide sequencing of a 1005-bp Sac I fragment was completed, and the rest of the fragments is ready to be sequenced. In addition, pulsed field gel electrophoresis and Southern hybridization analysis strongly suggest that the L.amazonensis contains at least three different types of P-glycoprotein gene, the Ldmdrl homologue, LtpgpA homologue and new type gene found in this study, but that chromosomal location of the LtpgpA is different from those of the other two genes.
利什曼原虫是一种含有多个P-糖蛋白基因的多基因家族。两种类型的基因(Ldmdrl和LtpgpA)已从不同的利什曼原虫物种中分离出来,并发现发挥耐药性的作用。在这项研究中,我们的目的是分离和表征的P-糖蛋白基因的亚马逊军团菌,在新大陆的皮肤利什曼病的病原体之一。利用哺乳动物和利什曼原虫P-糖蛋白基因保守序列特异性引物,通过聚合酶链反应(PCR)扩增亚马逊乳杆菌P-糖蛋白的ATP结合位点。结果表明,该片段与Ldmdr 1和LtpgpA的氨基酸序列同源性分别为68%和37%,表明该片段是新型利什曼原虫P-糖蛋白基因的一部分。为了从整体上分离出该基因,将亚马逊乳杆菌DNA的基因组文库构建到Adhesida-GEM-11载体中,并用PCR产物进行筛选。用Sac Ⅰ限制性内切酶消化其中一个阳性λ克隆,将所得DNA片段亚克隆到pUC 19载体中。目前,已完成了一个1005 bp的Sac I片段的核苷酸测序,其余片段已准备好测序。此外,脉冲场凝胶电泳和Southern杂交分析表明,亚马逊乳杆菌中至少含有3种不同类型的P-糖蛋白基因,即Ldmdr 1同源基因、LtpgpA同源基因和本研究发现的新类型基因,但LtpgpA基因的染色体定位与其它两个基因不同。
项目成果
期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
大友弘士: "微生物のVIRULENCE.原虫" Clinical Infection and Chemotherapy. 1. 38-41 (1995)
Hiroshi Otomo:“微生物的毒力。原生动物”《临床感染和化疗》1. 38-41 (1995)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Katakura, K.: "Evaluation of Glucantime (Meglumine Antimonate)lots in anti-Leishmania promastigote activity in vitro." Studies on New World leishmaniasis and its trans-mission, with particular reference to Ecuador.4. 30-33 (1994)
Katakura, K.:“评估葡聚糖时间(葡聚糖锑酸盐)批次的体外抗利什曼原虫前鞭毛体活性。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
大友弘士: "免疫検査実践マニュアルVIII感染症5.原虫疾患" 検査と技術. 22. 312-314 (1994)
大友博:《免疫学检测实用手册VIII传染病5.原虫病》检测与技术。 22. 312-314 (1994)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
片倉賢: "リーシュマニアの薬物療法とリーシュマニアの薬剤耐性" メディアサークル. (印刷中). (1995)
Ken Katakura:“利什曼原虫的药物治疗和利什曼原虫的耐药性”媒体圈(1995 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohtomo, H.: "Virulence of microorganisms : parasitic protozoa. (in Japanese)" Clinical Infection and Chemotherapy. 1. 38-41 (1995)
Ohtomo, H.:“微生物的毒力:寄生原生动物。(日语)”临床感染和化疗。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATAKURA Ken其他文献
KATAKURA Ken的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATAKURA Ken', 18)}}的其他基金
Epidemiological and genetic studies on vector-borne parasites and vectors in domesticated animals and chickens in Myanmar
缅甸家畜和鸡中媒介传播的寄生虫和媒介的流行病学和遗传学研究
- 批准号:
17H04638 - 财政年份:2017
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular epidemiology of hemoparasites of livestock and wild small mammals in Myanmar and Bangladesh
缅甸和孟加拉国家畜和野生小型哺乳动物血液寄生虫的分子流行病学
- 批准号:
26304035 - 财政年份:2014
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanisms of pathogenesis and parasite persistence in canine visceral leishmaniasis
犬内脏利什曼病发病机制和寄生虫持续存在的分子机制
- 批准号:
24380163 - 财政年份:2012
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular epidemiology of livestock parasitic diseases in Myanmar and northern Thailand and isolation of anti-parasitic compounds from medicinal plants
缅甸和泰国北部牲畜寄生虫病的分子流行病学及药用植物抗寄生虫化合物的分离
- 批准号:
22405037 - 财政年份:2010
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of diagnosis systems and development of chemotherapeutic drugs for leishmaniasis
利什曼病诊断体系建立及化疗药物开发
- 批准号:
18380178 - 财政年份:2006
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Leishmania multidrug resistance (MDR) proteins of ATP-binding cassette (ABC) transporters : subcellular localization of and the role in drug resistance
ATP结合盒(ABC)转运蛋白的利什曼原虫多药耐药(MDR)蛋白:亚细胞定位及其在耐药性中的作用
- 批准号:
13470055 - 财政年份:2001
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Roles of P-glycoprotein genes in drug resistance and intracellular parasitism in Leishmania
P-糖蛋白基因在利什曼原虫耐药和细胞内寄生中的作用
- 批准号:
10670241 - 财政年份:1998
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Extending the utility and durability of antifungal agents via innovative treatment regimens that minimise drug resistance
通过创新治疗方案最大限度地减少耐药性,延长抗真菌药物的效用和持久性
- 批准号:
MR/Y002164/1 - 财政年份:2024
- 资助金额:
$ 1.34万 - 项目类别:
Research Grant
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer
RNA m6A修饰在前列腺癌发病及耐药中的作用及机制
- 批准号:
10638634 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance
光滑念珠菌抗真菌药物耐药性中蛋白激酶的功能和转录组分析
- 批准号:
10643423 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
New approach based on enzyme stimulating of peptides for targeting drug resistance breast cancers
基于肽酶刺激的新方法用于靶向耐药性乳腺癌
- 批准号:
10713648 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Mechanisms of HIV fitness and drug resistance inferred from high-resolution molecular dynamics and sequence co-variation models
从高分辨率分子动力学和序列共变模型推断出 HIV 适应性和耐药性的机制
- 批准号:
10750627 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Reversing Drug Resistance in Tumors with Clickable Antibody Pairs
利用可点击的抗体对逆转肿瘤的耐药性
- 批准号:
10566266 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Mathematical Modeling of Drug Resistance Evolution and The Optimal Treatment Strategy in EGFR Mutated Lung Cancer
EGFR突变肺癌耐药演化的数学模型及最佳治疗策略
- 批准号:
22KJ0768 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Elucidation of prion strain-specific effect of antiprion drugs and drug resistance mechanisms
阐明抗朊病毒药物的朊病毒株特异性作用和耐药机制
- 批准号:
23H02828 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Targeting RAGE in tumor and TME to oppose inflammation and drug resistance in obesity associated ER+ breast cancer
靶向肿瘤和 TME 中的 RAGE,对抗肥胖相关 ER 乳腺癌的炎症和耐药性
- 批准号:
10734834 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Targeting chromosomal insatiability for overcoming drug resistance
针对染色体不饱和性克服耐药性
- 批准号:
23K08200 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




